Through
4/26
Alex Rees-Jones of the Wharton School co-authored a study that found that online learning during the pandemic had a negative impact on student learning.
Drew Weissman and Katalin Karikó earned the prestigious honor for their foundational research that led to development of two lifesaving mRNA COVID-19 vaccines.
If Black patients were admitted to the same hospitals that serve a majority of white patients, Penn Medicine researchers show their risk of death would drop by 10%.
The Rapid Response Grants for COVID-19 research projects have produced important new insights relevant to current pandemic response, as well as preparations for future infectious disease emergencies.
A challenging yet successful year—Penn’s exceptional community of dedicated students, faculty, and staff overcame the world’s most significant obstacles to flourish, from outreach locally through volunteerism, to helping the world globally with mRNA technology. The 2021 academic year highlighted the best of Penn.
The drug diABZI—which activates the body’s innate immune response—was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2 and likely other coronaviruses.
T cells can step up to do the job when antibodies are depleted, suggests a new Penn Medicine study of blood cancer patients with COVID-19.
The low-cost biosensor test developed by Penn Medicine could extend COVID-19 testing with 90% accuracy to remote and disadvantaged areas.
Tests of a new antiviral that aims to prevent the deadly Marburg virus from spreading in the body show promise, according to a study led by School of Veterinary Medicine researchers.
Key breakthroughs leading to the powerful mRNA vaccines against COVID-19 were forged at Penn, and the COVID-19 vaccines may only be the beginning of its impact on 21st-century medicine.
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →